NCT02337595
- Conditions
- Bone Marrow Diseases, Bone Marrow Failure Disorders, Bone Marrow Failure Syndromes, +18 more
- Locations
-
- Federal Research Center for pediatric hematology, oncology and immunology Moscow, Russia
Clinical trial condition
Leukemia, Myeloid
Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.
3,106 public trials
617 recruiting studies
Leukemia, Myeloid trial results
NCT00428909
- Conditions
- Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
- Locations
-
- Novartis Investigative Site Seoul, South Korea
NCT01542944
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- Chaim Sheba Medical Center Tel Litwinsky, Israel
NCT00750659
- Conditions
- Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +19 more
- Locations
-
- Chaim Sheba Medical Center Tel Litwinsky, Israel
NCT01075425
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +22 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- Virginia Commonwealth University Richmond, Virginia, United States
NCT01360125
- Conditions
- Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
- Locations
-
Not specified
NCT02733445
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia (CML), +11 more
- Locations
-
Not specified
Completed
Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia
NCT00623935
- Conditions
- Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- University of Michigan Cancer Center Ann Arbor, Michigan, United States
NCT01275196
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
- Locations
-
- Novartis Investigative Site Guangzhou, Guangdong, China
- Novartis Investigative Site Guangzhou, Guangdong, China
- Novartis Investigative Site Wuhan, Hubei, China
- Novartis Investigative Site Chengdu, Sichuan, China
Completed
Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal Response
NCT01043874
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia in Chronic Phase, +12 more
- Locations
-
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Aomori, Japan